Similarly, copy number increase (CNI) of TMPRSS2 and ERG without fusion was more frequent in Met/CRPC patients (33%) than in primary cancer patients (3%), suggesting increased genetic instability as the disease progresses, which was also observed in our studies of disseminated tumor cells obtained from prostate cancer patients [23], [26]. The gene discussed is TMPRSS2; the disease is neoplasm.